Coloplast (Germany) Analysis
| CBHD Stock | EUR 64.24 0.84 1.29% |
200 Day MA 78.4381 | 50 Day MA 71.7184 | Beta 0.592 |
Coloplast AS has over 5.08 Billion in debt which may indicate that it relies heavily on debt financing. At this time, Coloplast's Short and Long Term Debt is most likely to increase significantly in the upcoming years. The Coloplast's current Net Debt is estimated to increase to about 25.2 B, while Short Term Debt is projected to decrease to roughly 753 M. Coloplast's financial risk is the risk to Coloplast stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Coloplast's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Coloplast's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Coloplast Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Coloplast's stakeholders.
For many companies, including Coloplast, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Coloplast AS, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Coloplast's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 7.866 | Enterprise Value Ebitda 18.242 | Price Sales 0.5191 | Shares Float 143.4 M | Dividend Share 23 |
Given that Coloplast's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Coloplast is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Coloplast to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Coloplast is said to be less leveraged. If creditors hold a majority of Coloplast's assets, the Company is said to be highly leveraged.
The Coloplast's current Total Stockholder Equity is estimated to increase to about 21.7 B, while Other Stockholder Equity is forecasted to increase to (423.2 M). . Coloplast AS is overvalued with Real Value of 55.75 and Hype Value of 63.91. The main objective of Coloplast stock analysis is to determine its intrinsic value, which is an estimate of what Coloplast AS is worth, separate from its market price. There are two main types of Coloplast's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Coloplast's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Coloplast's stock to identify patterns and trends that may indicate its future price movements.
The Coloplast stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Coloplast's ongoing operational relationships across important fundamental and technical indicators.
Coloplast |
Coloplast Stock Analysis Notes
About 30.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.26. Coloplast AS last dividend was issued on the 5th of December 2025. The entity had 5:1 split on the 19th of December 2012. Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany. For more info on Coloplast AS please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.Coloplast Quarterly Total Revenue |
|
Coloplast AS Investment Alerts
| Coloplast AS generated a negative expected return over the last 90 days | |
| Coloplast AS has high historical volatility and very poor performance | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Coloplast AS Hits New 12-Month Low - Should You Sell - MarketBeat |
Coloplast Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 14.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Coloplast Profitablity
Coloplast's profitability indicators refer to fundamental financial ratios that showcase Coloplast's ability to generate income relative to its revenue or operating costs. If, let's say, Coloplast is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Coloplast's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Coloplast's profitability requires more research than a typical breakdown of Coloplast's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Management Efficiency
Coloplast AS has return on total asset (ROA) of 0.0985 % which means that it generated a profit of $0.0985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2726 %, meaning that it generated $0.2726 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Coloplast's Non Current Assets Total are most likely to increase significantly in the upcoming years.Management at Coloplast AS focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 24th of February, Coloplast shows the Risk Adjusted Performance of (0.01), standard deviation of 4.64, and Mean Deviation of 1.99. Coloplast AS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Coloplast AS treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Coloplast AS is priced correctly, providing market reflects its regular price of 64.24 per share.Coloplast AS Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Triangular Moving Average shows Coloplast double smoothed mean price over a specified number of previous prices (i.e., averaged twice).
Coloplast Outstanding Bonds
Coloplast issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Coloplast Predictive Daily Indicators
Coloplast intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Coloplast stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Coloplast Forecast Models
Coloplast's time-series forecasting models are one of many Coloplast's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Coloplast AS Debt to Cash Allocation
Many companies such as Coloplast, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Coloplast AS has accumulated 5.08 B in total debt with debt to equity ratio (D/E) of 43.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Coloplast AS has a current ratio of 1.1, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Coloplast until it has trouble settling it off, either with new capital or with free cash flow. So, Coloplast's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Coloplast AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Coloplast to invest in growth at high rates of return. When we think about Coloplast's use of debt, we should always consider it together with cash and equity.Coloplast Total Assets Over Time
Coloplast Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Coloplast's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Coloplast, which in turn will lower the firm's financial flexibility.Coloplast Corporate Bonds Issued
Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Coloplast Short Long Term Debt
Short Long Term Debt |
|
About Coloplast Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Coloplast prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Coloplast shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Coloplast. By using and applying Coloplast Stock analysis, traders can create a robust methodology for identifying Coloplast entry and exit points for their positions.
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Coloplast to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for Coloplast Stock analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |